DOCSLIB.ORG

Susan Dudek, RD, CDN, BS

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Susan Dudek, RD, CDN, BS Contributors Ryan Lloyd Albritton, MD Robert S. Langer, ScD Resident Physician Institute Professor Diagnostic Radiology Resident Department of Chemical Engineering Department of Radiology Massachusetts Institute of Technology UCSF Medical Center Cambridge, MA University of California, San Francisco San Francisco, CA Stephen C. Lazarus, MD Professor of Medicine Seth L. Alper, MD, PhD Department of Pulmonary & Critical Care Medicine Professor of Medicine, Harvard Medical School University of California, San Francisco Associate Physician, Department of Medicine San Francisco, CA Beth Israel Deaconess Medical Center Boston, MA Benjamin Leader, MD, PhD Senior Resident Physician April W. Armstrong, MD Department of Emergency Medicine Clinical Fellow Brown University Medical School Harvard Combined Dermatology Program, Harvard Medical Rhode Island Hospital School Providence, RI Department of Dermatology, Massachusetts General Hospital David C. Lewis, MD Boston, MA Donald G. Millar Distinguished Professor of Alcohol and Addiction Studies Ehrin J. Armstrong, MD, MSc Community Health and Medicine Clinical Fellow Center for Alcohol & Addiction Studies Department of Medicine Brown University Massachusetts General Hospital Providence, RI Boston, MA Allen Shuyuan Liu, MD Sarah R. Armstrong, MS, DABT Surgical Resident Senior Scientist Department of Surgery Cambridge Environmental Inc. Brigham and Women’s Hospital Cambridge, MA Boston, MA Ramy A. Arnaout, DPhil, MD Eng H. Lo, PhD Clinical Fellow in Pathology Professor, Radiology and Neurology Department of Pathology Harvard Medical School Brigham and Women’s Hospital Director, Neuroprotection Research Laboratory Boston, MA Departments of Neurology and Radiology Program for Evolutionary Dynamics Massachusetts General Hospital Harvard University Boston, MA Cambridge, MA Daniel H. Lowenstein, MD Alireza Atri, MD, PhD Professor of Neurology Instructor in Neurology Director, UCSF Epilepsy Center Harvard Medical School Department of Neurology Assistant in Neurology University of California, San Francisco Department of Neurology San Francisco, CA Massachusetts General Hospital Boston, MA Thomas Michel, MD, PhD Professor of Medicine (Biochemistry), Harvard Medical Jerry Avorn, MD School Professor of Medicine, Harvard Medical School Senior Physician, Cardiovascular Division, Brigham and Senior Physician and Chief, Division of Women’s Hospital Pharmacoepidemiology and Pharmacogenomics Boston, MA Brigham and Women’s Hospital Boston, MA Keith W. Miller, MA, DPhil Edward Mallinckrodt Professor of Pharmacology David A. Barbie, MD Department of Biological Chemistry and Molecular Chief Resident in Internal Medicine Pharmacology Department of Medicine Harvard Medical School Massachusetts General Hospital Pharmacologist Instructor in Medicine Department of Anesthesia and Critical Care Harvard Medical School Massachusetts General Hospital Boston, MA Boston, MA Robert L. Barbieri, MD Joshua D. Moss, MD Kate Macy Ladd Professor of Obstetrics, Gynecology and Fellow Reproductive Biology Cardiovascular Division Department of Obstetrics, Gynecology and Reproductive Hospital of the University of Pennsylvania Biology Philadelphia, PA Harvard Medical School Chairman Martin G. Myers, Jr., MD, PhD Department of Obstetrics and Gynecology Associate Professor of Medicine Brigham and Women’s Hospital Division of Metabolism, Endocrinology and Diabetes Boston, MA University of Michigan Medical School Ann Arbor, MI Mallar Bhattacharya, MD, MSc Senior Resident Mireya Nadal-Vicens, MD, PhD Department of Medicine Resident Tutor in Medicine Johns Hopkins Hospital Mather House Johns Hopkins University Harvard University Baltimore, MD Cambridge, MA Child and Adolescent Psychiatry Fellow Christopher W. Cairo, Ph.D. Department of Child and Adolescent Psychiatry Assistant Professor Massachusetts General Hospital Department of Chemistry Boston, MA University of Alberta Edmonton, AB Canada Dalia Shoretz Nagel, MD Resident Michael S. Chang, MD Department of Ophthalmology Department of Orthopaedic Surgery The Mount Sinai School of Medicine University of Iowa Hospitals and Clinics New York, NY Iowa City, IA Thomas P. Rocco, MD William W. Chin, MD Associate Professor of Medicine, Harvard Medical School Vice President Cardiovascular Division, Brigham and Women’s Hospital Discovery Research and Clinical Investigation Boston, MA Eli Lilly & Company Associate Chief, Cardiology Section, VA Boston Healthcare Volunteer Professor of Medicine System Department of Medicine West Roxbury, MA Indiana University School of Medicine Indianapolis, IN Harris S. Rose, MD Resident Deborah Yeh Chong, MD Department of Orthopaedic Surgery Ophthalmology Resident University of Texas Health Science Center - Houston Kellogg Eye Center Houston, TX University of Michigan Ann Arbor, MI Edward T. Ryan, MD Assistant Professor of Medicine, Harvard Medical School Janet Chou, MD Director, Tropical and Geographic Medicine Center, Division Clinical Fellow of Infectious Diseases, Massachusetts General Hospital Department of Pediatrics, Harvard Medical School Boston, MA Resident Department of Pediatric Medicine, Children’s Hospital Marvin Ryou, MD Boston Clinical & Research Fellow Boston, MA Division of Gastroenterology Brigham and Women’s Hospital Vinh Quoc Chung, MD, MPharmSci, MTh Boston, MA Dermatology Resident Department of Dermatology Joshua M. Schulman Emory University Harvard Medical School Atlanta, GA Boston, MA Jay Hwan Chyung, MD, PhD Charles N. Serhan, PhD Consultant Simon Gelman Professor of Anesthesia (Biological Boston Consulting Group Chemistry and Molecular Pharmacology), Harvard Boston, MA Medical School Director, Center for Experimental Therapeutics and David E. Clapham, MD, PhD Reperfusion Injury Aldo R. Castañeda Professor of Cardiovascular Research Department of Anesthesiology, Perioperative and Pain Director of Cardiovascular Research Medicine Professor of Pediatrics, Children’s Hospital Boston Brigham and Women’s Hospital Professor of Neurobiology, Harvard Medical School Boston, MA Boston, MA Helen M. Shields, MD Donald M. Coen, PhD Associate Professor, Harvard Medical School Professor of Biological Chemistry and Molecular Physician, Department of Medicine Pharmacology Beth Israel Deaconess Medical Center Harvard Medical School Boston, MA Boston, MA Steven E. Shoelson, MD, PhD David E. Cohen, MD, PhD Professor, Department of Medicine, Harvard Medical School Associate Professor, Harvard Medical School Associate Director, Research Division, Joslin Diabetes Director of Hepatology Center Department of Medicine, Brigham and Women’s Hospital Boston, MA Boston, MA Aimee D. Shu, MD John P. Dekker, PhD Clinical Fellow MD-PhD Student Division of Endocrinology Department of Neurobiology Department of Medicine Harvard Medical School Columbia University Medical Center Boston, MA New York, NY George D. Demetri, MD Josef B. Simon, MD Associate Professor of Medicine, Harvard Medical School Resident Director, Center for Sarcoma and Bone Oncology Orthopedic Surgery Department of Medical Oncology Harvard Medical School Dana-Farber Cancer Institute Massachusetts General Hospital Boston, MA Boston, MA Robert G. Dluhy, MD David G. Standaert, MD, PhD Professor of Medicine, Harvard Medical School Professor Senior Physician Department of Neurology Department of Medicine University of Alabama at Birmingham Brigham and Women’s Hospital Birmingham, AL Boston, MA Gary R. Strichartz, PhD David M. Dudzinski, MD, JD Professor of Anaesthesia, Harvard Medical School Clinical Fellow in Internal Medicine Director, Pain Research Center Department of Medicine Department of Anesthesiology, Perioperative and Pain Harvard Medical School Medicine Massachusetts General Hospital Brigham and Women’s Hospital Boston, MA Boston, MA Stuart A. Forman, MD, PhD Robert M. Swift, MD, PhD Associate Professor of Anaesthesiology Professor Department of Anaesthesiology, Harvard Medical School Department of Psychiatry & Human Behavior Associate Anesthetist Center for Alcohol & Addiction Studies Department of Anesthesia & Critical Care Brown University Massachusetts General Hospital Associate Chief of Staff for Research Boston, MA Providence Veterans Administration Medical Center Providence, RI David A. Frank, MD, PhD Assistant Professor of Medicine, Harvard Medical School Cullen Taniguchi, MD, PhD Assistant Professor, Department of Medical Oncology Postdoctoral Fellow Dana-Farber Cancer Institute Molecular and Cellular Physiology Boston, MA Joslin Diabetes Center Harvard Medical School Joshua M. Galanter, MD Boston, MA Fellow Pulmonary and Critical Care Medicine Armen H. Tashjian, Jr., MD University of California, San Francisco Professor of Biological Chemistry and Molecular San Francisco, CA Pharmacology, emeritus Harvard Medical School David E. Golan, MD, PhD Professor of Toxicology, emeritus Professor of Biological Chemistry and Molecular Harvard School of Public Health Pharmacology, Professor of Medicine, Harvard Medical Department of Genetics and Complex Diseases School Harvard School of Public Health Scholar and Founding Member, The Academy at Harvard Boston, MA Medical School Physician, Hematology Division, Brigham and Women’s Charles Russell Taylor, MD Hospital and Dana-Farber Cancer Institute Associate Professor Department of Biological Chemistry and Molecular Department of Dermatology Pharmacology, Department of Medicine Harvard Medical School Harvard Medical School Director of Phototherapy; Staff Dermatologist Boston, MA Department of Dermatology Massachusetts General Hospital Laura C. Green, PhD,
Load more

Recommended publications
  • Jerry Avorn, MD Is Professor of Medicine at Harvard Medical
    Promoting Biomedical Innovation and Economic Value: New Models for Reimbursement and Evidence Development Participant Biographies Jerry Avorn, MD is professor of medicine at Harvard Medical School and chief of the Division of Pharmacoepidemiology and Pharmacoeconomics in the Department of Medicine at Brigham and Women's Hospital. An internist, geriatrician, and drug epidemiologist, he studies the intended and adverse effects of prescription drugs, physician prescribing practices, and medication policy. The division he founded and leads comprises physicians, epidemiologists, health policy analysts, statisticians, and computer scientists who work together to analyze the utilization and outcomes of prescription drugs in numerous settings. Dr. Avorn pioneered the “academic detailing” approach to continuing medical education, in which non-commercial, evidence-based information about drugs is provided to doctors through educational outreach programs run by public-sector sponsors. Such programs are now in use in the United States, Canada, Australia, and Europe. Dr. Avorn completed his undergraduate training at Columbia University in 1969, received the MD from Harvard Medical School in 1974, and completed a residency in internal medicine at the Beth Israel Hospital in Boston. He is a member of the Institute of Medicine Committee on Standards for Developing Trustworthy Clinical Practice Guidelines and is the author or co-author of over 275 papers in the medical literature on medication use and its outcomes, and of the book, Powerful Medicines: The Benefits, Risks, and Costs of Prescription Drugs, now in its 11th printing. Robert Epstein, MD is Medco’s president of advanced clinical science and research, and chief clinical research and development officer. Dr. Epstein is responsible for all of Medco’s clinical research initiatives, including the Medco Research Institute™ and the United BioSource Research Divisions.
    [Show full text]
  • Workshop 2: Practical Approaches
    Examining the Impact of Real-World Evidence on Medical Product Development: A Workshop Series Workshop 2: Practical Approaches Workshop Briefing Materials Table of Contents 1. Workshop Information 2. Real-World Evidence Workshop Series Background Document 3. Workshop Agenda 4. Workshop Series Planning Committee Member Biographies 5. Workshop Speaker and Discussant Biographies 6. Literature Informing the Use Cases Being Discussed at the Workshop a. Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation (Patel et al. for the ROCKET-AF Investigators, 2011) b. Prospective Surveillance Pilot of Rivaroxaban Safety Within the US Food and Drug Administration Sentinel System (Chrischilles et al., 2017) c. Outcomes of Dabigatran and Warfarin for Atrial Fibrillation in Contemporary Practice: A Retrospective Cohort Study (Go et al., 2017) d. Lithium for Suicidal Behavior in Mood Disorders (Li+) (ClinicalTrials.gov record) e. Can Lithium Help Stem Suicide Rate? VA Study Aims to Find Out (VA Research Currents article) f. Use of Health Care Databases to Support Supplemental Indications of Approved Medications (Fralick et al., 2018) g. Comparison of Observational Data and the ONTARGET Results for Telmisartan Treatment of Hypertension: Bull’s-Eye or Painting the Target Around the Arrow? (Califf, 2018) Workshop Information Dates: March 6-7, 2018 Time: Day 1: 8:30am – 5:00pm Day 2: 8:30am – 12:30pm Location: National Academy of Sciences Building Room 120 2101 Constitution Ave NW Washington, DC 20418 Examining the Impact of Real-World Evidence on Medical Product Development: A Three-Part Workshop Series Washington, D.C. Background and Objectives Workshop Topics and Flow Workshop One (September 19-20, 2017) focused on Randomized, controlled clinical trials (RCTs) have how to align incentives to support collection and use traditionally served as the gold standard for evidence of real-world evidence in health product review, generation in support of medical product development and payment, and delivery.
    [Show full text]
  • Variations in Pill Appearance of Antiepileptic Drugs and the Risk of Nonadherence
    ORIGINAL INVESTIGATION ONLINE FIRST Variations in Pill Appearance of Antiepileptic Drugs and the Risk of Nonadherence Aaron S. Kesselheim, MD, JD, MPH; Alexander S. Misono, MD, MBA; William H. Shrank, MD, MSHS; Jeremy A. Greene, MD, PhD; Michael Doherty; Jerry Avorn, MD; Niteesh K. Choudhry, MD, PhD Background: Generic prescription drugs are bioequiva- Results: The AEDs dispensed had 37 colors and 4 shapes. lent to brand-name versions but may not have consis- A total of 11 472 patients with nonpersistence were linked tent color or shape, which can cause confusion and lead to 50 050 controls. Color discordance preceded 136 cases to interruptions in medication use. We sought to deter- (1.20%) but only 480 controls (0.97%) (adjusted odds mine whether switching among different-appearing an- ratio [OR], 1.27 [95% CI, 1.04-1.55]). Shape discor- tiepileptic drugs (AEDs) is associated with increased rates dance preceded 18 cases (0.16%) and 54 controls (0.11%) of medication nonpersistence, which can have serious (OR, 1.47 [95% CI, 0.85-2.54]). Within the seizure dis- medical, financial, and social consequences. order diagnosis subgroup, the risk of nonpersistence af- ter changes in pill color was also significantly elevated Methods: We designed a nested case-control study of com- (OR, 1.53 [95%, CI 1.07-2.18]). mercially insured patients in the United States who initi- ated an AED. Cases were patients who became nonpersis- Conclusions: Changes in pill color significantly tent, defined as failure to fill a prescription within 5 days of the elapsed days supplied.
    [Show full text]
  • Aaron Seth Kesselheim Curriculum Vitae
    Harvard Medical School Curriculum Vitae Date Prepared: April 28, 2020 Name: Aaron Seth Kesselheim, M.D., J.D., M.P.H. Office Address: Division of Pharmacoepidemiology and Pharmacoeconomics Department of Medicine, Brigham and Women’s Hospital 1620 Tremont Street, Suite 3030 Boston, MA 02120 Home Address: 25 Hillcroft Rd Jamaica Plain, MA 02130 Work Phone: (617) 278-0930 Work E-mail: [email protected] Work Website: http://www.drugepi.org/faculty-staff-trainees/faculty/aaron-kesselheim/ Work Fax: (617) 232-8602 Place of Birth: Cherry Hill, NJ Education 1996 A.B. (summa cum History and Science Harvard University, laude) Cambridge, MA 2002 M.D. Medicine University of Pennsylvania School of Medicine, Philadelphia, PA 2002 J.D. (magna cum Law University of Pennsylvania laude) Law School, Philadelphia, PA 2007 M.P.H. Clinical Effectiveness Harvard School of Public Health (HSPH), Boston, MA Postdoctoral Training 6/02-6/03 Intern Internal Medicine Brigham and Women’s Hospital (BWH), Boston, MA 7/03-6/05 Resident Internal Medicine BWH 7/05-6/07 Fellow General Medicine and Health Care BWH / Harvard Medical Policy Research School (HMS) / HSPH, Boston, MA Faculty Academic Appointments 7/07-6/10 Instructor Medicine HMS 7/08- Research Associate Health Policy and Management HSPH 7/10-6/14 Assistant Professor Medicine HMS 7/14-4/19 Associate Professor Medicine HMS 5/19- Professor Medicine HMS 7/14-7/15 Visiting Associate Law Yale Law School Professor of Law 7/16-7/19 Irving S. Ribicoff Law Yale Law School Visiting Associate 1 Professor of Law 7/19-7/20 Sidley Austin-Robert Law Yale Law School D.
    [Show full text]
  • Implications for Patients and Health Policy Speaker Biographies
    What Evidence is Essential for New Medical Products? Implications for Patients and Health Policy June 13, 2014 AAAS Headquarters Washington, DC Speaker Biographies Jerry Avorn, M.D. Harvard Medical School Jerry Avorn is Professor of Medicine at Harvard Medical School and Chief of the Division of Pharmacoepidemiology and Pharmacoeconomics in the Department of Medicine at Brigham and Women's Hospital. An internist and drug epidemiologist, he studies the intended and adverse effects of prescription drugs, physician prescribing practices, and medication policy. The division he founded and leads comprises physicians, epidemiologists, health policy analysts, statisticians, and computer scientists who work together to analyze patterns of utilization and outcomes of prescription drugs in numerous settings. Dr. Avorn pioneered the “academic detailing” approach to continuing medical education, in which non-commercial, evidence-based information about drugs is provided to doctors through educational outreach programs run by public-sector sponsors. Such programs are now in use in the U.S., Canada, Australia, and Europe. Dr. Avorn did his undergraduate work at Columbia University in 1969, received the M.D. from Harvard Medical School in 1974, and completed a residency in internal medicine at the Beth Israel Hospital in Boston. He has served as a member of the Institute of Medicine Committee on Standards for Developing Trustworthy Clinical Practice Guidelines and is the author or co-author of over 400 papers in the medical literature on medication use and its outcomes, and of the book, Powerful Medicines: The Benefits, Risks, and Costs of Prescription Drugs, now in its 11th printing. Robert Ball, M.D., M.P.H, Sc.M.
    [Show full text]
  • Download The
    Winter 2020–21 Columbia College Today THE GURUOF GOTHAM Mike Wallace ’64 is the “radical historian” behind the Pulitzer Prize-winning chronicles of New York City Columbia College’s distinctive academic experience is best achieved with a student body that is diverse in every way. Thanks to Columbia’s need-based, no-loan financial aid commitment, we can ensure that classes comprise students of all backgrounds, experiences and perspectives. In fact, more than 50 percent of Columbia College students receive financial assistance. Thousands of alumni, parents and friends have already contributed to the Core to Commencement campaign, helping to fulfill the College’s promise to fully meet each student’s demonstrated financial need, whether now or in the generations to come. Learn more and join the effort: college.columbia.edu/campaign. Contents Columbia College CCT Today VOLUME 48 NUMBER 2 WINTER 2020–21 EDITOR-IN-CHIEF Alexis Boncy SOA’11 EXECUTIVE EDITOR Lisa Palladino 14 20 30 DEPUTY EDITOR Jill C. Shomer ASSOCIATE EDITOR Anne-Ryan Sirju JRN’09 features FORUM EDITOR Rose Kernochan BC’82 14 CONTRIBUTING EDITORS James C. Katz ’72 The Guru of Gotham Alex Sachare ’71 Thomas Vinciguerra ’85 Mike Wallace ’64 is the “radical historian” behind the ART DIRECTOR Pulitzer Prize-winning chronicles of New York City. Eson Chan By Scott Meslow Published three times a year by Columbia College 20 for alumni, students, faculty, parents and friends. Star Search CHIEF COMMUNICATIONS AND MARKETING OFFICER Astrophysicist Rebecca Oppenheimer ’94 studies Bernice Tsai ’96 some of the oddest objects in the universe. ADDRESS By Matthew Hutson Columbia College Today Columbia Alumni Center 622 W.
    [Show full text]